Virbac (LTS:0NM7) Short Interest


LTS:0NM7 Virbac SA LTS:0NM7
91 GF Score
Price €322.50
GF Value €364.75
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Virbac Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0NM7 vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Virbac's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virbac Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's Short Interest distribution charts can be found below:

* The bar in red indicates where Virbac's Short Interest falls into.


LTS:0NM7
91GF Score
Virbac SA LTS:0NM7
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Virbac (LTS:0NM7) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be undervalued. The current stock price of €322.50 is trading 11.6% below its estimated GF Value™ of €364.75. GuruFocus considers Virbac to be Modestly Undervalued.

Key valuation signals for LTS:0NM7:

  • Short Interest:
  • GF Value™: €364.75 vs. price of €322.50 (11.6% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the LTS:0NM7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virbac Business Description

Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
91GF Score

Get the complete analysis for LTS:0NM7

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€322.50
Price
€364.75
GF Value